Latest Announcements

Investor Announcement

Prana Presents at World Orphan Drug Congress

Prana presents unique drug platform at World Orphan Drug Congress


Investor Announcement

Prana Maintains NASDAQ Listing

Prana regains compliance with NASDAQ continued listing requirements and continues to work towards FDA submission


Movement disorders expert Professor Ira Shoulson joins Prana Biotechnology's Board of Directors

Email Newsletter

Receive regular updates from Prana Biotechnology by entering your details below and clicking "Subscribe"